Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Global Traffic Network / Equity Capital Markets

<p>After its delisting from Nasdaq in 2011, Global Traffic Network (GTN) has launched its Australian IPO to raise up to US$186m. </p><ul><li>In this note, I examine its privatization, the current IPO, the industry, financials and valuation.</li><li>I also run the deal through our Smartkarma IPO framework. </li></ul>

After its delisting from Nasdaq in 2011, Global Traffic Network (GTN) has launched its Australian IPO to raise up to US$186m. In this note, I examine its privatization, the current IPO, the industry, financials and valuation.I also run the deal through our Smartkarma IPO framework. 

Global Traffic Network IPO: Recurring Business, Decent Yield